InvestorsHub Logo
Followers 484
Posts 61525
Boards Moderated 17
Alias Born 09/20/2001

Re: Battle Ready post# 205058

Wednesday, 08/07/2019 6:33:51 PM

Wednesday, August 07, 2019 6:33:51 PM

Post# of 468929
Not much. NTRP is way behind in their research. They've promised MS and not delivered.


XenaLives, if NTRP has a highly successful trial result, what will that mean for AVXL?



Anavex has trials for three different CNS diseases ongoing and a partnership for Schizophrenia study with Big Pharma in the mix.

NTRP has to first catch up on the depth of the data (severely impaired AD for a few weeks won't cut it). Then they have to prove they can make an affordable product. This will take several years and by then Anavex will be established SOC care they will have to PROVE their compound is better.

I don't remember seeing any gut microbiome data from NTRP. Regeneration of neurons could be the equivalent of jumping a dead battery.. It may get you home, but don't expect to get to work on time the next morning.



All IMO.. of course... LOL!




In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News